| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcellx, Inc. (ACLX) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. ACLX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 782.5K | $90.04M | - | |
| CFO | 45.3K | $5.21M | - | |
| Other | 23.7K | $2.73M | - | |
| Dir | 2.7K | $311.4K | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2024 | Patel Kavita55 | Director | Sale+OE | 10,000 | $54.27 | $542,656.50 | -66.5% | +56.3% | +20.8% | |
| Jun 26, 2024 | Gilson Michelle61 | Chief Financial Officer | Sell | 12,877 | $53.70 | $691,518.83 | -47.2% | +57.4% | +20.7% | |
| Jun 12, 2024 | Heery Christopher48 | Chief Medical Officer | Sale+OE | 20,000 | $55.13 | $1,102,668.10 | -51.8% | +34.7% | +20.8% | |
| May 24, 2024 | Gilson Michelle61 | Chief Financial Officer | Sale+OE | 12,121 | $50.71 | $614,655.91 | -38.0% | +28.1% | +23.2% | |
| May 1, 2024 | Heery Christopher48 | Chief Medical Officer | Sale+OE | 18,168 | $51.33 | $932,556.54 | -27.7% | +18.2% | +25.6% | |
| Apr 16, 2024 | Ware Olivia C | Director | Sale+OE | 9,402 | $55.55 | $522,259.59 | -78.3% | +14.7% | +9.9% | |
| Apr 1, 2024 | Elghandour Rami59 | See Remarks | Sell | 23,086 | $67.09 | $1,548,886.83 | -9.6% | -20.0% | -9.4% | |
| Mar 26, 2024 | Heery Christopher48 | Chief Medical Officer | Sale+OE | 46,815 | $70.06 | $3,279,713.91 | -31.0% | -20.0% | -0.0% | |
| Mar 21, 2024 | Carroll Jill56 | Director | Sell | 504,263 | $70.55 | $35,575,754.65 | -25.4% | -24.2% | -3.8% | |
| Mar 18, 2024 | Gilson Michelle61 | Chief Financial Officer | Sell | 6,825 | $69.34 | $473,255.49 | -23.7% | -22.2% | +1.1% |